Clarity Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Nov '24 Nov 6, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019 - 2018
Market Capitalization	2,245	1,689	182	132	-	-	Upgrade
Market Cap Growth	825.73%	825.73%	38.70%	-	-	-	Upgrade
Enterprise Value	2,108	1,651	107	35	-	-	Upgrade
Last Close Price	7.01	5.42	0.70	0.51	-	-	Upgrade
PE Ratio	-	-34.97	-7.35	-5.30	-	-	Upgrade
PS Ratio	166.41	146.79	18.62	20.37	-	-	Upgrade
PB Ratio	14.93	11.55	2.64	1.43	-	-	Upgrade
P/FCF Ratio	-38.62	-38.62	-6.62	-9.72	-	-	Upgrade
P/OCF Ratio	-39.07	-39.07	-6.64	-9.88	-	-	Upgrade
EV/Sales Ratio	183.21	143.49	10.87	5.40	-	-	Upgrade
EV/EBITDA Ratio	-36.98	-36.98	-4.06	-2.05	-	-	Upgrade
EV/EBIT Ratio	-36.86	-36.86	-4.04	-2.05	-	-	Upgrade
EV/FCF Ratio	-48.20	-37.75	-3.87	-2.58	-	-	Upgrade
Asset Turnover	0.10	0.10	0.11	0.11	0.20	0.29	Upgrade
Quick Ratio	18.44	18.44	9.95	13.19	9.91	9.43	Upgrade
Current Ratio	19.05	19.05	10.17	13.26	10.00	9.56	Upgrade
Return on Equity (ROE)	-39.29%	-39.29%	-30.48%	-42.23%	-71.89%	-80.00%	Upgrade
Return on Assets (ROA)	-24.19%	-24.19%	-18.65%	-17.40%	-40.63%	-45.29%	Upgrade
Return on Capital (ROIC)	-25.99%	-25.99%	-20.42%	-18.94%	-45.33%	-50.74%	Upgrade
Earnings Yield	-2.21%	-2.51%	-13.48%	-18.06%	-	-	Upgrade
FCF Yield	-1.95%	-2.59%	-15.10%	-10.28%	-	-	Upgrade
Buyback Yield / Dilution	-5.22%	-5.22%	-4.81%	-40.37%	-20.54%	-2.86%	Upgrade
Total Shareholder Return	-5.22%	-5.22%	-4.81%	-40.37%	-20.54%	-2.86%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.